CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

Miguel Quijada-Álamo, María Hernández-Sánchez, Verónica Alonso-Pérez, Ana E. Rodríguez-Vicente, Ignacio García-Tuñón, Marta Martín-Izquierdo, Jesús María Hernández-Sánchez, Ana B. Herrero, José María Bastida, Laura San Segundo, Michaela Gruber, Juan Luis García, Shanye Yin, Elisa ten Hacken, Rocío Benito, José Luis Ordóñez, Catherine J. Wu, Jesús María Hernández-Rivas

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences